Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why Ocugen Shares Are Falling

Ocugen FDA Nasdaq

Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 22.8% at $2.54 after the company announced the FDA declined to issue an EUA for COVAXIN for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 2 to 18 years of age.

Ocugen says the company intends to continue working with the FDA to evaluate the regulatory pathway for the pediatric use of COVAXIN.

Ocugen is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.

See Also: Why This Wheat-Focused ETF Is Suddenly On The Radar Of Retail Investors

Ocugen has a 52-week high of $17.65 and a 52-week low of $2.87.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Arcane creators say it'll be a long time before the next League of Legends adaptation lands on Netflix: 'We're not in production on those yet'
Arcane season 2 is almost over, but the award-winning Netflix show's creators "can't say" what they're working on next – and it's the internet's fault.
TechRadar
TechRadar
Melania and RFK Jr join forces to try to improve Trump’s diet: ‘Think fewer Big Macs and less KFC’
Incoming first lady and Trump’s pick for Health and Human Services secretary are apparently lobbying the president to make healthier choices
The Independent UK
The Independent UK
What are ‘Pink tote lid moments’? Dark TikTok trend explained
The dark trend has seen both young people and adults sharing troubling stories
The Independent UK
The Independent UK
Cruel Intentions review – this generic remake of the 90s classic is utterly mindless
Sarah Michelle Gellar and Ryan Phillippe’s movie gets a melodramatic YA remake – with a pair of actors who aren’t a patch on the originals. Just dig out the original instead
The Guardian - UK
The Guardian - UK
US moves to list giraffes under Endangered Species Act for first time
Climate crisis, habitat loss and poaching have reduced its numbers – but will Trump put the kibosh on protections?
The Guardian - US
The Guardian - US
“Who’s The One Actor That You Hate But Everyone Else Seems To Love?” (50 Answers)
No matter how popular they are, most celebrities have haters, too. Actors are no exception. The post “Who’s The One Actor That You Hate But Everyone Else Seems To Love?” (50 Answers) first appeared on Bored Panda.
Bored Panda
Bored Panda
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play